Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Preclinical Probes for Oncology Posters

  • You have access
    Targeted molecular imaging of c-Met in NSCLC using 68Ga-labeled binding peptide
    Xilin Sun, Zhaoguo Han, Ji Yan, Yang Liu, CHANGJIU ZHAO and Kai Wang
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1042;
  • You have access
    A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
    Shashikanth Ponnala, Alejandro Amor-Coarasa, James Kelly, Nicholas Zia, Williams Clarence, Anastasia Nikolopoulou, Paul Donnelly and John Babich
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1005;
  • You have access
    A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator.
    Simon Beaudoin, Sebastien Tremblay, Samia Ait-mohand, Jeff Leyton and Brigitte Guerin
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1009;
  • You have access
    Synthesis and biological evaluation of a novel γ-glutamyltranspeptidase activatable probe for PET imaging of tumors
    Ling Qiu, Siqin Ye and Jianguo Lin
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1037;
  • You have access
    Development of MDSC - CD11b tracer for immune PET imaging in glioblastoma model
    Shubhanchi Nigam, Lauren McCarl, Robert S Edinger, Rajeev kumar, Carolyn Anderson, Gary Kohanbash and W. Barry Edwards
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1035;
  • You have access
    Validation of 68Ga-4HMSA-PSMA, a novel PSMA radioligand for PET Imaging of Prostate Cancer
    Veronique Dumulon-Perreault, Samia Ait-mohand, Sebastien Tremblay, Etienne Rousseau, Éric Turcotte, Jean-Mathieu Beauregard, Frederic Pouliot and Brigitte Guerin
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1044;
  • You have access
    Nivolumab-DTPA as a Potential Qualitative and Quantitative Probe Platform for Assessing PD-1 Expression of Colon Cancer via Imaging
    Danni Li, Zhang Shi and Xiao Li
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1032;
  • You have access
    Production, labelingof novelnext-generationPET Nuclide Zirconium-89 and itsimmuno-PETImaging
    Feng Wang, Zhi Yang and Hua Zhu
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1058;
  • You have access
    Development of a new bifunctional PSMA ligand as a theranostic for prostate cancer
    Nicholas Zia, Carleen Cullinane, Jessica Van Zuylekom, Mohammad Haskali, Peter Roselt, Ellen van Dam, Matthew Harris, Rodney Hicks and Paul Donnelly
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1057;
  • You have access
    PET imaging of EGFR-positive tumors using an 18F-labeled peptide
    Shun Huang, Kongzhen Hu, Yanjiang Han and Penghui Sun
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1029;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire